European shares stay flat as oil surge lifts ECB hike bets
In short
European shares ended mostly flat. Higher oil prices and renewed US-Iran tensions raised inflation worries, but stronger euro zone data helped balance things out. Energy stocks rose, while Novartis fell after its cholesterol drug failed a key study.
This matters because investors are now expecting more ECB rate hikes, possibly in December. The final size of any policy move is still unknown.
What the reporting says
European shares closed largely flat as higher oil prices and renewed US-Iran tensions increased inflation concerns, while stronger euro zone data helped offset the pressure. Energy stocks gained, Novartis fell after its cholesterol drug failed a key study, and investors increased bets on further ECB rate hikes, including a possible December move. The immediate market direction was muted, but the policy outlook became more hawkish.
Why it matters
European shares closed largely flat as surging crude and renewed US-Iran tensions lifted inflation concerns, while stronger euro zone data supported sentiment. Energy stocks gained, but Novartis fell after its cholesterol drug failed a key study. Investors also raised bets on additional ECB rate hikes, including a possible December move, though the source does not say how likely or large any hike may be.